Attovia Therapeutics jobs and careers
Fremont, United States
About Attovia Therapeutics
Attovia is creating a pipeline of biotherapeutics with an initial focus on immune-mediated disease and oncology. We leverage ATTOBODY, a novel biologics platform, to generate small format biparatopic binders that unlock the spatial aspect of target engagement. The biparatopic binding mode of ATTOBODIES translates to picomolar affinity with glue-like off-rates, exquisite specificity, and accelerated target internalization. Their small format and modularity offer fast tissue penetration, ease of engineering into bispecifics, and tunable half-life from hours to weeks. Collectively, these properties of ATTOBODIES expand the addressable target and epitope universe across disease areas and can offer stronger efficacy, faster speed to response, and an improved safety profile compared to traditional approaches. By utilizing our ATTOBODY technology, we will develop novel medicines that target unaddressed elements of disease, as well as offer better efficacy and tolerability. We envision a world where no patient is left behind.
- Employees
- 11 to 50
- Headquarters
- Fremont
Leadership
The top of Attovia Therapeutics's org chart, with how many people report into each leader.
Tao Fu
Chief Executive Officer
31 reports
Petter Veiby
Chief Scientific Officer
9 reports
Hubert Chen
Chief Medical Officer
6 reports
Steven Chan
Chief Financial Officer
4 reports
Zaneta Odrowaz
Chief Business Officer
3 reports
Hangjun Zhan
Chief Technology Officer
1 report
David King
CSO And Co-founder
1 report
Luisa Salter - Cid
CSO
Jobs at Attovia Therapeutics
No open positions right now. Explore more companies on TheJobsMap.